Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell wall is a rigid, protective structure primarily composed of **peptidoglycan**, a mesh-like polymer of alternating N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM) units cross-linked by short peptide bridges[2][3][4][5]. This structure determines bacterial shape, prevents osmotic lysis, and is essential for viability[1][7][11]. Gram-positive bacteria have thick peptidoglycan layers with teichoic acids, while gram-negative bacteria have thin peptidoglycan surrounded by an outer membrane containing lipopolysaccharide[1][6][12][14]. Cell wall synthesis and remodeling involve numerous enzymes (Mur family, penicillin-binding proteins), many of which are validated antibiotic targets due to their essential roles in growth and division[9][4][11]. Therapeutic targeting of the cell wall or its biosynthetic proteins remains a cornerstone of antibacterial therapy, but clinical efficacy is challenged by resistance and drug hypersensitivity. Note: For structured information, "Peptidoglycan (bacterial cell wall)" is correct only if referring to the wall's polymeric structure. For a protein target, specify the protein (e.g., Penicillin-binding protein 2). "Bacterial cell wall/protein" as written is overly broad and should be clarified for data interoperability.
Inhibition of cell wall (peptidoglycan) biosynthesis (by blocking transpeptidase or other biosynthetic enzymes) Disruption of cell wall structure, leading to osmotic lysis and cell death[4][7][9]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidoglycan (bacterial cell wall).